期刊文献+

反向前列腺特异性膜抗原增强子启动子调控重组质粒的构建及增强子调控活性的比较 被引量:1

Constructing Recombinant Plasmid with Prostate-specific Membrane Antigen Promoter and Reverse Enhancer and Comparing the Transcription Activity of Enhancers in Different Directions
下载PDF
导出
摘要 目的探讨前列腺特异性膜抗原(PSM A)启动子和增强子调控目的基因表达的前列腺细胞特异性,了解增强子增强转录效率的能力。方法采用PCR方法从前列腺癌细胞DNA中分别扩增PSM A增强子序列,将其按不同方向亚克隆到含有报告基因——绿色荧光蛋白(GFP)的重组质粒载体pEGFP-PSM AP ro,脂质体介导基因转染不同癌细胞并观察GFP在所转染的细胞的表达情况。结果成功构建质粒pEGFP-PSM AE-P和pEGFP-PSM AE(r)-P,质粒转染结果显示PSM A表达阳性的LNC aP细胞中存在GFP的特异有效表达,增强子序列能使基因转录效率提高30倍,不同方向的增强子序列在增强转录效率方面具有同样效应。结论反向PSM A增强子启动子调控GFP表达的重组质粒的构建证明该调控序列具有前列腺细胞特异性,增强子具有增强启动子转录效率的功能且没有方向性。 Objective To assess the specificity of prostate-specific membrane antigen(PSMA) promoter and enhancer in controlling gene expression and to compare the activity of enhancers in different directions for choosing the most suitable prostate-specific PSMA controlling elements. Methods PSMA enhancer gene was amplified with PCR, then the enhancer gene was subcloned into the expressing vector pEGFP-PSMAPro reversely to construct the recombinant plasmid pEGFP-PSMAE(r)-p, which was transfected into different cell lines such as LNCaP, PC-3,MCF-7,A549. Green fluorescent protein(GFP) expression was observed and compared to other recombinants constructed previously. Results The recombinant plasmid with reverse enhancer was successfully constructed, the PSMA promoter and enhancer showed modulating activity in PSMA-expressed cell line uniquely. PSMA enhancer could increase 30-fold transcriptional activity over the basal level achieved by PSMA promoter alone, and no impact of the direction on the activity of enhancer was noted. Conclusion PSMA promoter/enhancer is specific to PSMA-expressed cells. The transcriptional activity of reverse enhancer is similar to that of enhancer. PSMA promoter/enhancer has the potential for use in targeted gene therapy of prostate adenocarcinoma.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2005年第6期782-785,共4页 Journal of Sichuan University(Medical Sciences)
关键词 前列腺特异性膜抗原 启动子 反向增强子 前列腺癌 绿色荧光蛋白 Prostate-specific membrane antigen Promoter Reverse enhancer Prostate adenocarcinoma Green fluorescent protein
  • 相关文献

参考文献12

  • 1Harrington KJ, Spitzweg C, Bateman AR, et al. Gene therapy for prostate cancer. J Urol,2001;166(4):1220.
  • 2曾浩,李虹,廖咏川,李响,吴琦,杨宇如.前列腺特异性膜抗原启动子调控的重组质粒的构建及表达[J].四川大学学报(医学版),2005,36(2):169-171. 被引量:2
  • 3Isaceli RS, Powell CT, Fair WR, et al.Expression of the prostate-specific membrane antigen. Cancer Res, 1994;54(7):1807.
  • 4O'Keefe DS, Su SL, Bacich DJ, et al. Mapping, genomic organization and promoter analysis of the human prostatespecific membrane antigen gene. Biochimica et Biophysica Acta,1998;1443(1 - 2):113.
  • 5Uchida A, O'keefe DS, Bacich DJ, et al. In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: a potential alternative approach to androgen deprivation therapy. Urology,2001;58(2 Suppl 1):132.
  • 6Watt F, Martorana A, Brookes DE, et al. A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1. Genomics,2001;73(3):243.
  • 7O'keefe DS, Uchida A,Bacich DJ, et al.Prostate-specific suicide gene therapy using theprostate-specific membrane antigen promoter and enhancer. The Prostate,2000;45(2):149.
  • 8Lee SJ, Lee K, Yang X, et al.NFATc1 with AP-3 site binding specificity mediates gene expression of prostate-specific-membrane-antigen. J Mol Biol, 2003;330(4):749.
  • 9Noss KR, Wolfe SA, Grimes SR. Upregulation of prostate specific membrane antigen/folate hydrolase transcription by an enhancer. Gene,2002;285(1 - 2):247.
  • 10Watt FB, Brookes DE, Ho T, et al.A tissue-specific enhancer of the prostate-specific membrane antigen gene. Genomics, 2001;73(3):243.

二级参考文献8

  • 1Carter RE, Feldman AR, Coyle JT, et al. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc Natl Acad Sci USA,1996;93(2):749.
  • 2Isaceli RS, Miller WH, Su SL, et al. Sensitive nested transcription polymerase chain reaction detection of circulating prostate tumor cells: comparison of PSMA and PSA based assay. Cancer Res ,1994;54(24): 6306.
  • 3O'Keefe DS, Su SL, Bacich DJ, et al. Mapping, genomic organization and promoter analysis of the human prostatespecific membrane antigen gene. Biochimica et Biophysica Acta,1998;1443(1 - 2) :113.
  • 4Good D, Schwarzenberger P, Eastham JA, et al. Cloning and characterization of the prostate-specific membrane antigen promoter. J Cell Biochem. 1999;74(3):395.
  • 5Watt F, Martorana A, Brookes DE, et al. A tissue-specific enhancer of the prostate-specific membrane antigen gene,FOLH1. Genomics, 2001;73(3):243.
  • 6Noss KR, Wolfe SA, Grimes SR. Upregulation of prostate specific membrane antigen/folate hydrolase transcription by an enhance. Gene,2002;285(1 - 2) :247.
  • 7Lu Y, Carracher J, Zhang Y, et al. Delivery of adenoviral vectors to the prostate for gene therapy. Cancer Gene Ther,1999;6(1) :64.
  • 8Smale ST. Transcription: Mechanisms and Regulation. New York: Raven Press, 1994:63 - 81.

共引文献1

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部